ALZAMEND NEURO INC (ALZN:NASDAQ)

$1.22 0.075 (6.5502%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 81

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed ALZAMEND NEURO INC (ALZN:NASDAQ) News Sources

Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

16-06-2025

yahoo.com

Alzamend Neuro Reports Annual 2025 Financial Results and Provides Update on Clinical Programs

23-07-2025

yahoo.com

Alzamend Neuro to Present at the 2025 Military Health System Research Symposium

28-07-2025

yahoo.com

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants

19-11-2025

yahoo.com

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

19-11-2025

yahoo.com

EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth?

20-11-2025

yahoo.com

Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?

26-01-2026

yahoo.com

Alzamend Neuro Initiates Phase II Clinical Trial of AL001 "Lithium in Brain" Study in Patients with Bipolar Disorder in Collaboration with Massachusetts General Hospital

16-03-2026

yahoo.com

Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions

26-03-2026

yahoo.com

Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital

07-04-2026

yahoo.com

ALZAMEND NEURO INC (ALZN:NASDAQ) Sentiment Trend

0 25 50 75 100 78 61 78 87 80 83 83 85 89 81 16-06-2025 23-07-2025 28-07-2025 19-11-2025 20-11-2025 26-01-2026 16-03-2026 26-03-2026 07-04-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

ALZAMEND NEURO INC (ALZN:NASDAQ) FAQs

toggle

What is the current price of ALZAMEND NEURO INC (ALZN:NASDAQ)?

The current price of ALZAMEND NEURO INC (ALZN:NASDAQ) is $1.22.


toggle

ALZAMEND NEURO INC (ALZN:NASDAQ) absolute price change since previous trading day?

The absolute price change of ALZAMEND NEURO INC (ALZN:NASDAQ) since the previous trading day is $0.075.


toggle

ALZAMEND NEURO INC (ALZN:NASDAQ) percentage price change since previous trading day?

The percentage price change of ALZAMEND NEURO INC (ALZN:NASDAQ) since the previous trading day is 6.5502%.


toggle

What is the most recent average sentiment score for ALZAMEND NEURO INC (ALZN:NASDAQ)?

The most recent average sentiment score for ALZAMEND NEURO INC (ALZN:NASDAQ) is 81 out of 100.


toggle

What is the most recent average sentiment for ALZAMEND NEURO INC (ALZN:NASDAQ)?

The most recent sentiment for ALZAMEND NEURO INC (ALZN:NASDAQ) is .


SEC-8K** Filing Available For ALZAMEND NEURO INC (ALZN:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.